Hematology News

Rivaroxaban reduced risk for recurrent venous thromboembolism compared with warfarin among patients with VTE and obesity, according to study results presented during International Society on Thrombosis and Haemostasis 2020 Virtual Congress.

The 62nd annual ASH Annual Meeting and Exposition will not be held in San Diego as planned.

Blood donations from people on antiretroviral therapy to treat HIV or pre-exposure prophylaxis to prevent HIV infection could increase risk for HIV transfusion transmission if tests cannot detect the virus in the donations, study results showed.

Vaporized cannabis did not significantly reduce chronic pain and most associated symptoms compared with placebo among adults with sickle cell disease, according to results of a randomized study published in JAMA Network Open.

Endotheliopathy among patients with COVID-19 appeared associated with severe illness and death, according to study results published in The Lancet Haematology.

COVID-19 has brought up the use of the old remedy convalescent serum. What is it? Did it work? This series walks us through the history of the serum, how it was discovered, how it was first used, and how it inspired the field of immunology.

Investigators have identified inflammatory proteins, known as neutrophil extracellular traps, that may contribute to the onset of cardiac complications among patients with COVID-19 infection, according to study results published in Blood.

Trauma patients who underwent emergency general surgery appeared to have a twofold higher risk for venous thromboembolism than patients who underwent elective surgery, according to study results published in JAMA Surgery.

Negative perceptions of care in the ED setting appeared to be a barrier to seeking care among adolescents and adults with sickle cell disease, according to results of a prospective survey-based study published in JAMA Network Open.

Abnormalities in blood clotting have been linked to increased mortality risk among patients with COVID-19.